What are the immunologically active components of Bacille Calmette-Guérin in therapy of superficial bladder cancer?Alexandre R. Zlotta, Kris Huygen, Jacques Simon et al.|International Journal of Cancer|2000Cited by 65
Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.Alexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|PubMed|1997Cited by 45
Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder CancerAlexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|The Journal of Urology|1997Cited by 39
SUPERFICIAL BLADDER TUMORS AND INCREASED REACTIVITY AGAINST MYCOBACTERIAL ANTIGENS BEFORE BACILLUS CALMETTE-GUERIN THERAPYAlexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|The Journal of Urology|1998Cited by 10
Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder CancerAlexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|The Journal of Urology|1997Cited by 1